Hexaethylene Glycol

Hexaethylene Glycol

SCHEMBL4379136

Cc1ccc(S(=O)(=O)O)cc1.Cc1ccc(S(=O)(=O)O)cc1.OCCOCCOCCOCCOCCOCCO

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1BMXBRAFBTKCHRNA4CHRNB2CSNK1EEGFRERBB2F10FLT1FLT3FLT4IGF1RINSRITKJAK3KDRKITOPRM1PARP1PARP2PDGFRBPIK3CDRAF1RETSLC18A2TECTXKdacAdacBdacCftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hexaethylene Glycol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.49
CYP2C9 P11712 2/20 0.46
CYP1A2 P05177 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.44
LMNA P02545 2/20 0.44
MAPT P10636 2/20 0.44
KDM4E B2RXH2 1/20 0.44
HTT P42858 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
CYP2D6 P10635 2/20 0.43
RECQL P46063 1/20 0.42
GAA P10253 1/20 0.42
SNCA P37840 1/20 0.41
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
MMP1 P03956 1/20 0.40
MMP2 P08253 1/20 0.40
MMP9 P14780 1/20 0.40
MMP8 P22894 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29137364 1.00 ALDH1A1 (0.49) ALDH1A1CYP2C9CYP1A2SMN1; SMN2LMNA
SCHEMBL29249377 1.00 ALDH1A1 (0.49) ALDH1A1CYP2C9CYP1A2SMN1; SMN2LMNA
SCHEMBL28704841 1.00 ALDH1A1 (0.49) ALDH1A1CYP2C9CYP1A2SMN1; SMN2LMNA
SCHEMBL28618062 1.00 ALDH1A1 (0.49) ALDH1A1CYP2C9CYP1A2SMN1; SMN2LMNA
Pentaethylene Glycol SCHEMBL3466434 1.00 ALDH1A1 (0.49) ALDH1A1CYP2C9CYP1A2SMN1; SMN2LMNA
Hexaethylene Glycol SCHEMBL11280667 1.00 ALDH1A1 (0.49) ALDH1A1CYP2C9CYP1A2SMN1; SMN2LMNA
Tetraethylene Glycol SCHEMBL1145155 1.00 ALDH1A1 (0.49) ALDH1A1CYP2C9CYP1A2SMN1; SMN2LMNA
Tetraethylene Glycol SCHEMBL3062384 1.00 ALDH1A1 (0.49) ALDH1A1CYP2C9CYP1A2SMN1; SMN2LMNA
Triethylene Glycol SCHEMBL6130636 1.00 ALDH1A1 (0.49) ALDH1A1CYP2C9CYP1A2SMN1; SMN2LMNA
SCHEMBL27633211 1.00 ALDH1A1 (0.49) ALDH1A1CYP2C9CYP1A2SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122012012-A High-strength low-temperature-resistant recyclable adhesive and preparation method thereof 四川大学 2026-05-12 CN claimed
CN-122012012-A High-strength low-temperature-resistant recyclable adhesive and preparation method thereof 四川大学 2026-05-12 CN disclosed
EP-4652160-A1 COMPOUNDS FOR NUCLEIC ACID CLEAVAGE Cambridge Enterprise Limited (GB) 2025-11-26 EP disclosed
US-20250332318-A1 POLYMER PARTICLES TERUMO CORP (JP) 2025-10-30 US disclosed
US-12364786-B2 Polymer particles TERUMO CORPORATION (JP) 2025-07-22 US disclosed
US-20240417778-A1 Methods for Nucleic Acid Cleavage CAMBRIDGE ENTERPRISE LIMITED (GB) 2024-12-19 US disclosed
EP-4423295-A2 METHODS FOR NUCLEIC ACID CLEAVAGE Cambridge Enterprise Limited (GB) 2024-09-04 EP disclosed
WO-2024153950-A1 COMPOUNDS FOR NUCLEIC ACID CLEAVAGE CAMBRIDGE ENTERPRISE LIMITED (GB) 2024-07-25 WO disclosed
WO-2024153952-A1 COMPOUNDS FOR NUCLEIC ACID CLEAVAGE CAMBRIDGE ENTERPRISE LIMITED (GB) 2024-07-25 WO disclosed
EP-3518994-B1 POLYMER PARTICLES TERUMO CORP (JP) 2024-02-07 EP disclosed
WO-2021078301-A1 PROTEIN DEGRADING AGENT AND USE THEREOF IN TREATMENT OF DISEASES 上海科技大学 2021-04-29 WO disclosed
US-20200255689-A1 POLISHING COMPOSITION AND METHOD OF FABRICATING SEMICONDUCTOR DEVICE USING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-08-13 US disclosed
US-20200215222-A1 POLYMER PARTICLES MICROVENTION, INC. 2020-07-09 US disclosed
US-10201632-B2 Polymer particles TERUMO CORPORATION (JP) 2019-02-12 US disclosed
US-20180085497-A1 POLYMER PARTICLES TERUMO CORPORATION (JP) 2018-03-29 US disclosed
US-8436197-B2 Palladium complexes and polymerization and coupling processes thereof WEST CHESTER UNIVERSITY OF PENNSYLVANIA OF THE STATE SYSTEM OF HIGHER EDUCATION (US) 2013-05-07 US disclosed
US-20090111962-A1 Palladium Complexes and Polymerization and Coupling Processes Thereof WEST CHESTER UNIVERSITY OF PENNSYLVANIA OF THE STATE SYSTEM OF HIGHER EDUCATION 2009-04-30 US disclosed
US-6441164-B2 A CROWN ETHER SUBSTITUTED BY EITHER ONE OR BOTH OF THE NITROGEN OF AN N,N'-DI-C1-C4-ALKYL-P-PHENYLENEDIAMINE; REDOX ACTIVE; BINDING METALS AND METAL IONS; DETECTORS; CHARGE TRANSFER COMPOUNDS; SWITCHES; MRI CONTRAST AGENTS EAST CAROLINA UNIVERSITY 2002-08-27 US disclosed
US-20010047095-A1 A crown ether substituted by either one or both of the nitrogen of an N,N'-di-C1-C4-alkyl-p-phenylenediamine; redox active; binding metals and metal ions; detectors; charge transfer compounds; switches; MRI contrast agents SIBERT JOHN W (US) 2001-11-29 US disclosed
US-6262258-B1 UEFUL AS REDOX SWITCHES, SENSORS, TRANSPORT AGENTS, AND ELECTROCATALYSTS EAST CAROLINA UNIVERSITY 2001-07-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200215222-A1 POLYMER PARTICLES FGB, PLG, PLAT ALDH1A1 3057/4885CYP2C9 3457/4885CYP1A2 3886/4885
US-20250332318-A1 POLYMER PARTICLES FGB, PLG, PLAT ALDH1A1 3057/4885CYP2C9 3457/4885CYP1A2 3886/4885
US-12364786-B2 Polymer particles FGB, PLG, PLAT ALDH1A1 3057/4885CYP2C9 3457/4885CYP1A2 3886/4885
US-20090111962-A1 Palladium Complexes and Polymerization and Coupling Processes Thereof DDT, PDCD2L, PDCD1LG2 ALDH1A1 1671/4885CYP2C9 2211/4885CYP1A2 3534/4885
US-10201632-B2 Polymer particles FGB, PLG, PLAT ALDH1A1 3057/4885CYP2C9 3457/4885CYP1A2 3886/4885
US-20010047095-A1 A crown ether substituted by either one or both of the nitrogen of an N,N'-di-C1-C4-alkyl-p-phenylenediamine; redox active; binding metals and metal ions; detectors; charge transfer compounds; switches; MRI contrast agents CBR3, CBR1, AOC3 ALDH1A1 3095/4885CYP2C9 1192/4885CYP1A2 720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.